Fennec Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $17,874 | $15,108 | $13,777 | $12,462 |
Gross Profit | 17,153 | 14,538 | 12,013 | 11,802 |
EBITDA | 1,763 | 234 | -4,347 | -26 |
EBIT | 1,737 | 208 | -4,373 | -52 |
Net Income | 1,973 | 201 | -4,787 | -638 |
Net Change In Cash | 17,874 | 15,108 | 13,777 | 12,462 |
Free Cash Flow | 50 | 2,379 | -5,962 | 1,493 |
Cash | 41,249 | 40,179 | 36,788 | 21,947 |
Basic Shares | 36,430 | 35,548 | 31,175 | 27,889 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $44,642 | $47,538 | $21,252 | $1,535 |
Gross Profit | 40,878 | 44,354 | 19,993 | 1,449 |
EBITDA | -7,452 | 4,798 | -12,364 | -22,587 |
EBIT | -7,555 | 3,998 | -12,651 | -22,736 |
Net Income | -9,741 | -436 | -16,045 | -23,714 |
Net Change In Cash | 44,642 | 47,538 | 21,252 | 1,535 |
Free Cash Flow | -12,473 | 26,980 | -17,143 | -18,058 |
Cash | 36,721 | 26,634 | 13,269 | 23,774 |
Basic Shares | 28,577 | 27,294 | 26,574 | 26,275 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.05 |
2026-03-31 | $0.01 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.02 |